Verso Corporation (NYSE:VRS) tinted loss of -0.49% (-0.09 points) to US$18.14. The volume of 0.28 Million shares climbed down over an trading activity of 478.47 Million shares. EPS ratio determined by looking at last 12 month figures is -0.93. Over the same time span, the stock marked US$19.75 as its best level and the lowest price reached was US$3.17. The corporation has a market cap of US$631.45 Million.

Verso Corporation (NYSE:VRS)’s earnings per share has been growing at a 22.3 percent rate over the past 5 year when average revenue increase was noted as 10.8 percent. The return on equity ratio or ROE stands at -4.1 percent while most common profitability ratio return on investment (ROI) was -0.1 percent. The company’s institutional ownership is monitored at 76.4 percent. The company’s net profit margin has achieved the current level of -1.2 percent and possesses 9.1 percent gross margin.

Daily Analyst Recommendations

A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 0 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 0 think it is Hold. Recently, analysts have updated the overall rating to 2. 2 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.

PLDT Inc. (NYSE:PHI) is worth US$5.66 Billion and has recently fallen -0.49% to US$26.19. The latest exchange of 0.07 Million shares is below its average trading activity of 80.08 Million shares. The day began at US$26.34 but the price moved to US$26.1 at one point during the trading and finally capitulating to a session high of US$26.34. The stock tapped a 52-week high of US$38.54 while the mean 12-month price target for the shares is US$30.48.

Currently, the stock carries a price to earnings ratio of 22.08, a price to book ratio of 2.76, and a price to sales ratio of 1.84. For the past 5 years, the company’s revenue has grown 0%, while the company’s earnings per share has grown -5.49%. With an institutional ownership near 9.05%, it carries an earnings per share ratio of 1.19.

Inside Look At Analysts Reviews

Latest analyst recommendations could offer little help to investors. The stock is a Buy among 0 brokerage firms polled by Factset Research. At present, 1 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 0 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 3.